Fundraising Fox
/Companies
Sign in

Connect Biopharma

NASDAQ: CNTB

San Diego, US · 2 known investors

Find your way into Connect Biopharma

Each arrow is one introduction. Sign up to fill in the first one.

732 people can intro you to David

Ask Wills Hapworth to introduce you to David Szekeres

You →Wills · together at Ipswich Town FC →David

219 people can intro you to Kimberly

Ask Jamie Chen to introduce you to Kimberly J. Manhard

You →Jamie · together at Shoreline Biosciences, Inc. →Kimberly

9 people can intro you to Barry

Ask Sam Okafor to introduce you to Barry D. Quart

You →Sam · together at Heron Therapeutics, Inc. →Barry

Sign up to find every way you can get introduced to Connect Biopharma

  • Your email: who you already know at Connect Biopharma, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Connect Biopharma team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Connect Biopharma is a clinical-stage biopharmaceutical company developing antibody-based therapies targeting inflammatory diseases such as atopic dermatitis and asthma. The company operates globally with headquarters in San Diego and operations in the U.S. and China.

BiotechHealthtech

Founders & leadership

BDBarry D. Quart
Barry D. QuartChief Executive OfficerBarry D. Quart is Chief Executive Officer and Director of Connect Biopharma. He has over 30 years of experience in biotechnology and pharmaceutical development, including 16 years as a public biotech CEO; he co-founded Ardea Biosciences in 2006 and served as its CEO until its acquisition by AstraZeneca in 2012, and most recently led Heron Therapeutics as CEO overseeing the development and launch of multiple drugs. He holds a Pharm.D. from the University of California, San Francisco.
DSDavid Szekeres
David SzekeresPresidentDavid Szekeres is President of Connect Biopharma, a clinical-stage biopharmaceutical company developing antibody-based therapies for inflammatory diseases. He has held executive roles spanning operations, commercial, corporate development, strategy, finance, investor relations, and legal functions.
KJ
Kimberly J. ManhardChief Development Officer, Executive VPKimberly J. Manhard serves as Executive Vice President and Chief Development Officer at Connect Biopharma, a clinical-stage biopharmaceutical company developing antibody-based therapies for inflammatory diseases. She brings experience in pharmaceutical drug development and corporate governance within the biotechnology sector.

Investors · 2

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

Frequently asked questions

What does Connect Biopharma do?
Connect Biopharma is a clinical-stage biopharmaceutical company developing antibody-based therapies targeting inflammatory diseases such as atopic dermatitis and asthma. The company operates globally with headquarters in San Diego and operations in the U.S. and China.
Who are Connect Biopharma's investors?
Connect Biopharma's investors include Co-Win Ventures, RA Capital.
Where is Connect Biopharma headquartered?
Connect Biopharma is headquartered in San Diego, US.